Faster Blood Processing Could Improve Gestational Diabetes Diagnosis During Pregnancy
A study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
A study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
The U.S. FDA has granted a Breakthrough Device Designation for the Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers.
Read MoreScientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
Read MoreOmegaQuant has been awarded a grant to develop a dried blood spot test identifying fatty acid patterns that predict metabolic syndrome and type 2 diabetes as early screening tools.
Read MoreNew research from NIH found that blood glucose levels obtained at childhood examinations predicted future diabetes-related complications.
Read MoreIt’s hoped new understanding of the GCK gene and its role in the development of diabetes could help increase the usefulness of DNA sequencing.
Read MoreDigital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read MoreOrange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MoreAnalyzing changes to DNA in the blood can improve the ability to predict a person’s risk of developing type 2 diabetes within a decade.
Read MoreThe new panels are designed to target dozens of microbially-derived metabolites across multiple pathways to advance pre-clinical efforts.
Read MoreA recent study compared the gut microbiota and gut-derived metabolites between healthy controls and individuals with fatty liver.
Read MoreA research team has identified a new non-invasive screening method for Type 2 diabetes (T2D) by harnessing urinary acetones.
Read MoreThe method uses molecular profiling and AI to develop dietary signatures to predict cardiovascular disease and type 2 diabetes risks.
Read MoreA scientist is developing health information tech designed to enhance accessibility and value to adults with diabetes and Alzheimer’s disease.
Read MoreJourney Biosciences, a company offering predictive risk-screening technologies for diabetes complications, launch its flagship product.
Read MoreUsing a standard diabetes test to screen all adults in U.K. aged 40-70 years would find undiagnosed cases of type 2 diabetes much earlier.
Read More